| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,746 |
20,514 |
$2.51M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,717 |
11,064 |
$2.29M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,527 |
4,286 |
$752K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,081 |
2,004 |
$342K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,567 |
2,476 |
$239K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
20,656 |
17,110 |
$201K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,464 |
5,177 |
$195K |
| 71045 |
Radiologic examination, chest; single view |
3,804 |
3,608 |
$190K |
| 62323 |
|
846 |
784 |
$160K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,696 |
16,756 |
$127K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,392 |
3,172 |
$122K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,365 |
1,265 |
$111K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,635 |
2,453 |
$95K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,637 |
2,455 |
$95K |
| 80053 |
Comprehensive metabolic panel |
10,719 |
9,359 |
$80K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,166 |
1,013 |
$68K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,363 |
2,248 |
$64K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,683 |
1,603 |
$54K |
| 71046 |
Radiologic examination, chest; 2 views |
804 |
772 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,088 |
1,016 |
$36K |
| 81001 |
|
9,526 |
9,009 |
$30K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
745 |
675 |
$30K |
| 36591 |
|
2,702 |
1,952 |
$29K |
| 70450 |
Computed tomography, head or brain; without contrast material |
167 |
161 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,618 |
3,366 |
$25K |
| 0225U |
|
58 |
56 |
$23K |
| 86780 |
|
992 |
928 |
$21K |
| 84484 |
|
2,414 |
2,259 |
$20K |
| 81025 |
|
2,176 |
2,017 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
853 |
805 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
487 |
465 |
$19K |
| 87088 |
|
1,650 |
1,541 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
199 |
183 |
$13K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
501 |
481 |
$12K |
| 11056 |
|
1,022 |
1,007 |
$10K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
185 |
107 |
$10K |
| 83735 |
|
1,755 |
1,614 |
$10K |
| 83690 |
|
1,204 |
1,124 |
$8K |
| J3490 |
Unclassified drugs |
1,090 |
805 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
985 |
815 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
115 |
103 |
$7K |
| 86762 |
|
371 |
349 |
$7K |
| 86850 |
|
440 |
411 |
$6K |
| 82728 |
|
524 |
488 |
$6K |
| 86003 |
|
57 |
54 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,700 |
2,295 |
$5K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
14 |
14 |
$5K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
458 |
427 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
13 |
$5K |
| 84466 |
|
444 |
413 |
$5K |
| 87340 |
|
393 |
368 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
162 |
51 |
$4K |
| 86803 |
|
204 |
183 |
$4K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
13 |
13 |
$4K |
| 86787 |
|
231 |
211 |
$4K |
| 0352U |
|
110 |
106 |
$4K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
16 |
12 |
$4K |
| 83880 |
|
174 |
129 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
695 |
651 |
$3K |
| 86592 |
|
690 |
674 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
144 |
141 |
$3K |
| 83540 |
|
442 |
413 |
$3K |
| 87430 |
|
176 |
172 |
$2K |
| 11721 |
|
439 |
433 |
$2K |
| 86900 |
|
441 |
412 |
$2K |
| 86901 |
|
441 |
412 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
38 |
37 |
$2K |
| 82962 |
|
692 |
643 |
$2K |
| 73630 |
|
15 |
15 |
$956.61 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
150 |
141 |
$945.89 |
| 84443 |
Thyroid stimulating hormone (TSH) |
43 |
39 |
$878.98 |
| 81003 |
|
340 |
317 |
$815.51 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
58 |
55 |
$797.23 |
| 20610 |
|
12 |
12 |
$760.54 |
| 87081 |
|
111 |
107 |
$736.21 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
38 |
37 |
$721.46 |
| 11720 |
|
161 |
160 |
$680.68 |
| 82950 |
|
110 |
109 |
$655.73 |
| 77002 |
|
12 |
12 |
$622.08 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
28 |
27 |
$587.98 |
| 86703 |
|
313 |
302 |
$544.00 |
| 87210 |
|
79 |
75 |
$497.09 |
| 94060 |
|
28 |
28 |
$491.95 |
| 94729 |
|
29 |
29 |
$489.03 |
| 94726 |
|
28 |
28 |
$489.03 |
| A4217 |
Sterile water/saline, 500 ml |
73 |
42 |
$412.12 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
147 |
138 |
$396.41 |
| 82785 |
|
54 |
41 |
$386.70 |
| J2704 |
Injection, propofol, 10 mg |
59 |
36 |
$379.54 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$378.00 |
| 84480 |
|
15 |
12 |
$368.42 |
| 84436 |
|
42 |
38 |
$348.27 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
137 |
119 |
$344.24 |
| 85027 |
|
65 |
64 |
$310.15 |
| 84702 |
|
26 |
25 |
$261.60 |
| 87070 |
|
26 |
26 |
$257.52 |
| 83970 |
|
16 |
15 |
$245.99 |
| 85018 |
|
79 |
78 |
$241.24 |
| 85014 |
|
78 |
77 |
$238.29 |
| 80061 |
Lipid panel |
14 |
14 |
$233.80 |
| 94664 |
|
29 |
29 |
$230.40 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
40 |
38 |
$227.16 |
| 83605 |
|
37 |
37 |
$224.75 |
| 83525 |
|
13 |
13 |
$185.25 |
| 87807 |
|
14 |
14 |
$128.52 |
| 36000 |
|
12 |
12 |
$112.91 |
| 84479 |
|
12 |
12 |
$89.16 |
| 82947 |
|
13 |
13 |
$63.57 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
93 |
84 |
$61.69 |
| 80069 |
|
12 |
12 |
$39.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13 |
13 |
$35.78 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12 |
12 |
$30.24 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
232 |
185 |
$17.23 |
| 94375 |
|
26 |
26 |
$0.00 |